Galectin Therapeutics Announces Achievement of Key Milestones Related to NASH-CX Clinical Trial
February 01, 2017 08:10 ET
|
Galectin Therapeutics
NORCROSS, Ga., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced it has generated...
Galectin Therapeutics to Webcast Corporate Update At Annual Meeting of Stockholders
December 08, 2016 08:00 ET
|
Galectin Therapeutics
NORCROSS, Ga., Dec. 08, 2016 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company...
Ocera to Present at the Cowen and Company 36th Annual Health Care Conference
February 29, 2016 16:05 ET
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...
AuraSense Therapeutics Announces Publication of Preclinical Data Demonstrating Immuno-Modulation by its Proprietary Spherical Nucleic Acid Platform
April 22, 2015 16:01 ET
|
Exicure, Inc.
SKOKIE, Ill., April 22, 2015 (GLOBE NEWSWIRE) -- AuraSense Therapeutics, the pioneer in developing Spherical Nucleic Acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, today...
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on International Stem Cell Corporation
August 06, 2013 08:30 ET
|
Crystal Research Associates, LLC
NEW YORK, NY--(Marketwired - Aug 6, 2013) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on International Stem Cell...
Ocera Therapeutics Announces Completion of Merger With Tranzyme
July 15, 2013 12:04 ET
|
Ocera Therapeutics, Inc.
SAN DIEGO, July 15, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. ("Ocera"), a clinical stage biopharmaceutical company developing novel therapeutics for orphan liver diseases, and Tranzyme, Inc....
CDC Recommends One-Time Hepatitis C Test for All Baby Boomers
August 16, 2012 12:52 ET
|
CDC Foundation
Industry and community partners applaud CDC's work to protect people from viral hepatitis, support CDC's efforts through Faces of Hepatitis video stories project
ATLANTA, Aug. 16, 2012 (GLOBE...
Oxis International Inc Receives GRAS Status for its Patented L-Ergothioneine Anti-Oxidant
October 10, 2011 08:30 ET
|
OXIS International Inc.
Beverly Hills, California, Oct. 10, 2011 (GLOBE NEWSWIRE) -- Oxis International Inc. (OTC/Bulletin Board: OXIS.OB and Euronext: OXI.PA) today announced that an independent scientific panel of experts...